Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect?

Rigel Pharmaceuticals (RIGL) closed the last trading session at $19.9, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $33.74 indicates a 69.6% upside potential.The average comprises six short-term price targets ranging from a low of $20.45 to a high of $57.00, with a standard deviation of $17.29. While the lowest estimate indicates an increase of 2.8% from the current ...